You are required to be logged in to access the full website
Click here if you have forgotten your username or password
16 June 2026 - Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc (Nasdaq:INVA) focused on innovative therapies in critical care and infectious disease, said on Tuesday that it has entered into an exclusive distribution and licensing agree...
16 June 2026 - Swedish biotech company AlzeCure Pharma AB (Nasdaq First North Premier Growth Market:ALZCUR) on Tuesday reported positive results from the completed Phase Ib clinical study of ACD856, its lead NeuroRestore drug candidate being develope...
16 June 2026 - Minghui Pharmaceutical, a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, announced on Monday the presentation of complete Phase I/II clinical data for MHB0...
16 June 2026 - Clinical-stage biotechnology company Kalohexis Inc announced on Monday that data supporting dual melanocortin-3 receptor/melanocortin-4 receptor (MC3R/MC4R) activation as a novel mechanism to drive healthier, more durable weight loss h...
16 June 2026 - Hillhurst Biopharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing novel oral liquid drug products based on known inhaled therapeutics, announced on Monday that the first subject has been dosed in its Ph...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe